IQVIA (IQV) Income Statement Flow — TTM through Q2 2026
Calculated from the four most recent reported quarters, ending (reported ).
IQVIA (IQV) Revenue by Product Segment — TTM through Q2 2026
Aggregated from the four quarterly disclosures behind this TTM. Minor differences vs the company's annual filing can occur if reported segments changed mid-year.
| Segment | Revenue (USD) | % of total |
|---|---|---|
| Research And Development Solutions | $9.52B | 56% |
| Technology And Analytics Solutions | $6.98B | 41.1% |
| Contract Sales And Medical Solutions | $491M | 2.9% |
| Total | $17B | 100% |
- Research And Development Solutions$9.52B
- Technology And Analytics Solutions$6.98B
- Contract Sales And Medical Solutions$491M
- Total$17B
IQVIA (IQV) Revenue by Geography — TTM through Q2 2026
Aggregated from the four quarterly disclosures behind this TTM. Minor differences vs the company's annual filing can occur if reported regions changed mid-year.
| Region | Revenue (USD) | % of total |
|---|---|---|
| Americas | $9.96B | 47.4% |
| EMEA | $6.73B | 32% |
| Asia Pacific | $4.31B | 20.5% |
| Total | $21B | 100% |
- Americas
- EMEA
- Asia Pacific
- Total
Revenue Breakdown — TTM through Q2 2026
In TTM through Q2 2026, IQVIA (IQV) reports revenue across 3 reportable product segments; the largest segment was Research And Development Solutions at 56%, followed by Technology And Analytics Solutions (41.1%) and Contract Sales And Medical Solutions (2.9%). Geographically, Americas accounted for 47.4% of revenue, followed by EMEA (32%) and Asia Pacific (20.5%).
Frequently asked questions
Data & methodology
IQVIA (IQV) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.